International Journal of
Environmental Research
and Public Health
Article
Non-Surgical Treatment of Periodontal Disease in a
Pregnant Caucasian Women Population: Adverse
Pregnancy Outcomes of a Randomized Clinical Trial
LeticiaCaneiro-Queija1,JoseLópez-Carral1,2,PabloMartin-Lancharro1,2,
JacoboLimeres-Posse1,3,*,PedroDiz-Dios1,3andJuanBlanco-Carrion1
1 Medical-SurgicalDentistryResearchGroup(OMEQUI),HealthResearchInstituteofSantiagode
Compostela(IDIS),UniversityofSantiagodeCompostela(USC),15782SantiagodeCompostela,Spain;
leticiacaneiro@gmail.com(L.C.-Q.);carralami@gmail.com(J.L.-C.);
pablo.martin.lancharro@sergas.es(P.M.-L.);pedro.diz@usc.es(P.D.-D.);jblanco@blancoramos.net(J.B.-C.)
2 DepartmentofObstetricsandGynecology,ClinicUniversityHospitalofSantiagodeCompostela,
15782SantiagodeCompostela,Spain
3 SpecialNeedsUnit,SchoolofMedicineandDentistry,SantiagodeCompostelaUniversity,
15782SantiagodeCompostela,Spain
* Correspondence: jacobo.limeres@usc.es;Tel.:+3-48-8156-2026;Fax:+3-49-8156-2226
(cid:1)(cid:2)(cid:3)(cid:1)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:1)
(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)
Received: 9August2019;Accepted: 24September2019;Published: 27September2019
Abstract: Aim: To analyze if non-surgical treatment of periodontitis in a pregnant Caucasian
women population can reduce adverse pregnancy outcomes. Methods and results: A parallel
randomizedclinicaltrialwasdesignedandapprovedbytheEthicalCommitteeofSanitaryArea
Santiago-Lugo,Spain(registrationnumber: 2016/451). FortypatientswithperiodontitisstageIIgrade
Bwererandomlyallocatedtoreceiveeithercomprehensivenon-surgicalperiodontaltherapy(test
group; n=20) or professional tooth cleaning (control group; n = 20) before 24 gestational weeks.
Randomizationwascomputer-generatedbythestatisticprogramEpidatv.4.1andallocationwas
performedusingsealedopaqueenvelopes. Clinicalmeasurementsandperipheralbloodsamplesfor
biochemicalvariableswerecollectedatbaseline,inthemiddleofsecondtrimesterbeforenon-surgical
treatment, and in the third trimester. Microbiological samples were collected in the second and
thirdtrimester. Astatisticallysignificantreductionwasverifiedinallclinicalandmicrobiological
parametersafterperiodontaltreatmentinthetestgroup. Nosignificantdifferenceswereobserved
fortherestofthevariables, includingpretermbirthand/orlowbirthweight. Noadverseevents
relatedtoperiodontaltreatmentwerereported. Conclusions: Non-surgicalperiodontaltreatmentin
CaucasianpatientswithperiodontitisstageIIgradeBdidnotsignificantlyreducetheriskofadverse
pregnancyoutcomes.
Keywords: pretermbirth;lowbirthweight;pregnancy;periodontaldisease
1. Introduction
Adverse results of pregnancy, such as preterm birth or low birth weight, can be the cause of
mortality and increased morbidity in neonates [1]. Worldwide, preterm birth is the second most
commonfactorofdeathinchildrenunder5yearsold[2].
The prevalence of preterm births varies depending on the country (ranged from 5% in some
European countries to 18% in some African countries). Blencowe et al. [3] identified data from
99countriesandestimatedthe2010globalprevalenceat11.1%(95%CI=9.1–13.4%). Thepreterm
birthrateinthe1980swasnotvastlydifferentthanthecurrentpretermbirthrate[4],anditremainsan
importantpublichealthpriorityworldwide[5].
Int.J.Environ.Res.PublicHealth2019,16,3638;doi:10.3390/ijerph16193638 www.mdpi.com/journal/ijerph
Int.J.Environ.Res.PublicHealth2019,16,3638 2of14
Periodontitisisaninflammatoryinfectiondiseaseaffectingthetooth-supportingtissues,initiated
by a biofilm with gram-negative anaerobic microorganism predominance and mediated by the
inflammatoryresponseofthehost. Itisalsoliabletoinducesystemicinflammationandconsequently
modify the normal development of pregnancy [6]. During pregnancy, due to hormonal changes,
theremaybeatendencytowardsperiodontaldisease,inparticular,thereisanincreaseofanaerobic
gram-negative bacteria such as Fusobacterium nucleatum, Treponema denticola, Tannerella forsythia,
Campylobacterrectus,Eikenellacorrodens,andSelenomonassputigena[7].
Infections account for 75% of premature births and/or low birth weight, while subclinical
infectionsbegintobeconsideredasanimportantcauseofveryprematurebirth(beforethe30thweekof
gestation). However,inmorethan50%ofcases,theetiologicalfactorsofprematurityareunknown[8].
Oralinfectionsmightbeconsideredoneofthesefactors,sincecommensalbacterialspeciesoftheoral
cavitycolonizethefetoplacentalunitofwomenwithfull-termgestationandwithadversepregnancy
outcomes[9]. Thebacterialspeciesmoststronglyassociatedwithadversepregnancyoutcomesinclude:
Fusobacteriumnucleatum,Campylobacterrectus,Porphyromonasgingivalis,andBergeyellaspp.[10].
Twomainrouteshavebeenproposedtotriggeraninflammatoryresponseinthefetoplacentalunit;
thedirectroute,inwhichtheoralmicroorganismsand/ortheircomponentsreachthefetoplacentalunit
byhematogenousdisseminationoftheoralcavityorbyanascendingroutethroughthegenitourinary
tract;andtheindirectroute,inwhichtheinflammatorymediatorsproducedintheperiodontaltissues
circulateandimpactthefetoplacentalunit. Alargenumberofstudiesassociateanincreaseinthelevels
oflocalandsystemicinflammatorymarkerswithadversepregnancyoutcomes[11]. Aswellasthis,
hormonalchangesduringpregnancy,duetoelevatedlevelsofestrogenandprogesterone,increase
vascularpermeabilityingingivaltissuesand,asaconsequence,bacteriaand/ortheirproductscan
diffusemoreeasily[12].
Theincreaseinmaternalserumlevelsofproinflammatorycytokines,suchasIL-1,IL-6,IL-8,and
TNF-αhavebeenassociatedwithprematurityandlowbirthweight[13,14]. C-reactiveprotein,which
isanacute-phasereactantsynthesizedbytheliverinresponsetoproinflammatorycytokines,hasalso
beenassociatedwithprematurity[15].
Cohortstudieshaveshownarelationshipbetweenperiodontaldisease,prematuredelivery,and
lowbirthweight[16–18],asithasbeenconfirmedinsomesystematicreviews[19–22]. Ontheother
hand,clinicaltrialshavestudiedtheeffectofperiodontaltreatmentonadversepregnancyoutcomes
andshowedcontroversialresults[8,21–31]. Thisisprobablybecausethereisamarkedheterogeneity
betweenstudiesintermsofthepopulation´scharacteristics(race,age,etc.) aswellastheperiodontitis
definitionapplied. Finally,itshouldbenotedtheconclusionsreachedintheNineEuropeanWorkshop
on Periodontology in 2012 indicating that, up to now, it is not possible to affirm that periodontal
treatmentreducestheratesofprematuredeliveryorbirthofunderweightchildren[32]. However,
thesestudieshaveprovidedthatnon-surgicalperiodontaltreatment,whenperformedonpregnant
women,issafeforthemotherandthefetus[32,33].
Ourhypothesiswasthatperiodontitishasaneffectonpregnancyoutcomes,suchaspretermbirth
and/orlowbirthweight. Therefore,theaimofthecurrentstudyistoanalyzeifnon-surgicaltreatment
ofperiodontitis,usingthedefinitionsuggestedbytheEFP-AAPConsensusMeeting[34],canreduce
adversepregnancyoutcomesinapregnantCaucasianwomenpopulation.
2. MaterialandMethods
2.1. StudyDesign
Aparallelrandomizedclinicaltrialwasdesignedtotestwhetherthenon-surgicalperiodontal
treatmentprovidedduringpregnancyaffectedgestationalageatdeliveryandbirthweight. Datawere
gatheredonthepregnantwomenatthreevisits: attheendofthefirsttrimester(16weeksofpregnancy),
inthemiddleofsecondtrimester(22–24weeksofpregnancy),andatthethirdtrimester(33–36weeks
Int.J.Environ.Res.PublicHealth2019,16,3638 3of14
ofpregnancy),asusuallyrecommendedfollow-upvisitsinpregnantwoman. Norelevantchanges
wereperformedaftertrialcommencement.
2.2. StudyPopulation
Pregnant women who were seen for prenatal care at the University Hospital of Santiago de
Compostela(Spain)wereinvitedtoparticipateinthestudywhentheyattendedthehospitaltoundergo
thefirstgynecologicalclinicappointmentbetweenJune2017andMay2018. Duringthisscreeningvisit,
afull-mouthperiodontalexaminationwasperformedandpatientswithaperiodontitisdiagnosis[34]
wereinvitedtoparticipate. ThesamplesizewasdonewithPASSv.12(NCSS,LCC;Kaysville, UT,
USA)withan80%powerandasignificancelevelof0.05,samplesizewasestablishedas40patients.
Thepatientswhowereincludedinthestudyweredividedintwogroups(testandcontrol)according
toapreviouscomputer-generatedrandomization(generatedbythestatisticprogramEpidatv. 4.1)
andallocationratio1:1(usingsealedopaqueenvelopeslabeledwithastudynumberandcontaining
thegroupallocationopenedbyexaminerafterbaselineexamination). Thetestgroupcorrespondedto
patientswithnon-surgicalperiodontaltreatment,andthecontrolgroupconsistedofpatientswithout
periodontal treatment (Figure 1). All potential participants signed an informed consent form to
participateinthestudy. ThisprotocolwasapprovedbytheEthicalCommitteeoftheSanitaryArea
Santiago-Lugo,Spain(reference: 2016/451).
Figure1. Researchoutline.
2.3. Inclusion/ExclusionCriteria
Inclusion criteria were Caucasian pregnant women (gestational age ≤16 weeks), aged 18 to
40years,withmorethan20naturalteethanddiagnosisofperiodontitis.
Exclusion criteria were multiple gestation; previous preterm low birth weight; more than 1
previousmiscarriageoronegreaterthan18weeks;diabetes;hypertension;alcoholism;drugabuse;
humanimmunodeficiencyvirus(HIV)infection;heartdisease,kidneydiseaseorliverdisease;recurrent
cystitis;viralinfections;venerealinfections;toxoplasmosis;and/ortobaccosmoking.
2.4. MaternalCharacteristics
Demographicdataandmedicalhistorywereassessedbyinterviewduringthefirstvisit(16th
gestationalweek). Theinterviewincludeditemsonage,educationallevel(primaryorless,highschool,
anduniversity),areaofresidence(ruralorurban,dependingonthenumberofinhabitants),bodymass
index(BMI),maritalstatus(single,common-lawpartner,married),andobstetrichistory(numberof
previouspregnancies,previousmiscarriage).
The following variables were recorded shortly after delivery: newborn weight, newborn sex,
durationofpregnancy,andtypeofdelivery(vaginalorcaesarean).
2.5. PeriodontalMeasurements
Full-mouthperiodontalexaminationswereperformedbyoneexaminer. Theweightedκvalues
forintra-examinercalibrationwere0.82(CI95%=0.68–0.98). Periodontalclinicalmeasurementswere
recordedatenrolmentandrepeatedat2ndand3rdtrimester. Examsincludedallteethpresentin
Int.J.Environ.Res.PublicHealth2019,16,3638 4of14
themouth(excludingthirdmolars). Aplaquescore[35],periodontalpocketdepth(PPD)(sixsites
pertooth),clinicalattachmentlevel(CAL)andbleedingonprobing(BOP)[35](sixsitespertooth)
were registered. All scores were measured with a manual periodontal probe UNC-15 (Hu-Friedy,
Chicago,IL,USA).PeriodontitiswasdefinedaccordingtothecasedefinitionsoftheWorldWorkshop
inPeriodontologyin2018[34]:
1. InterdentalCALwasdetectableat≥2non-adjacentteeth,or
2. BuccalororalCAL≥3mmwithpocketing≥3mmwasdetectableat≥2teethbuttheobserved
CALcouldnotbeascribedtonon-periodontitis-relatedcausessuchas: (1)gingivalrecession
oftraumaticorigin;(2)dentalcariesextendinginthecervicalareaofthetooth;(3)presenceof
CALonthedistalaspectofasecondmolarandassociatedwithmalpositionorextractionofa
thirdmolar;(4)anendodonticlesiondrainingthroughthemarginalperiodontium;and(5)the
occurrenceofaverticalrootfracture.
2.6. BiochemicalVariables
Aperipheralbloodsamplewascollectedfromeachsubjectwithvenipunctureusingavacuum
tube(Vacutainer,NipponBectonDickinsonTokyo,Japan). Sampleswerecentrifugedat2500rpm
for10minutesandtheserumobtainedwasdissociatedinaplastictube. Atthetimeoftheanalyses,
theserumconcentrationofinterleukin-6(IL-6),interleukin-8(IL-8),tumornecrosisfactor-α(TNF),
andfibrinogenweredeterminedusingcommerciallyavailableenzyme-linkedimmunoassays(ELISA).
2.7. MicrobiologicalVariables
Inthemiddleofthesecondtrimester(22–24weeksofpregnancy)beforenon-surgicalperiodontal
treatmentandbeforethethirdtrimester,foursites(thosewiththedeepestprobingdepth)wereselected,
andtwoconsecutivepaperpointswereinsertedandkeptinplacefor10s. Allpaperpointswere
pooledinavialwithreducedtransportfluid(RTF)andtransferredtothelaboratorywithin12h[36].
Theobtainedsamplesweredispersed(30sofvortex),seriallydilutedandprocessedforculture
byinoculationontwodifferentmedia: bloodagarmedium(no2;OxoidLtd.,Basingstoke,UK),with
horseserumat5%andwithhemin(5mg/L)andDentaid-1medium[37]. Thebloodagarplateswere
◦
studiedafter14daysofanaerobicincubation(80%N ;10%H ;10%CO )at37 C,andafter3–5days
2 2 2
◦
at37 Cinairwith5%CO .
2
Porphyromonasgingivalis,Prevotellaintermedia,Tannerellaforsythia,Parvimonamicra,Campylobacter
restus, Fusobacteriumnucleatum, Eikenellacorrodens, andCapnocytophagaspp., wereidentifiedbased
mainlyontheircolonymorphologyandfurtherconfirmedwithdifferentspecificchemicaltests. Counts
for every bacterial species were obtained and the percentage relative to the total flora calculated.
AggregatibacteractinomycetemcomitansweregrownonDentaid-1mediumplates,andidentifiedbased
oncolonymorphologyandcatalasereaction.
2.8. PeriodontalTreatment
Thetestgrouppatientsreceivednon-surgicalperiodontaltherapythatwascompletedbythe
end of week 24 of gestation. This consisted of oral hygiene instructions, followed by mechanical
supraandsubgingivalscalingandrootplanning(SRP)withGraceycurettes(Hu-Friedy, Chicago,
IL,USA).Periodontaltherapywasperformedovertwo1-hoursessions. Periodontaltreatmentwas
performedbyoneperiodontist(L.C.)intheDepartmentofPeriodontologyattheUniversityofSantiago
deCompostela(Spain).
Thecontrolgroupreceivedprofessionaltoothcleaning(oralhygieneinstructionsandsupragingival
cleaningofallteeth)atthesecond-trimestervisit. Allcontrolparticipantswereofferedtheopportunity
toattendfornon-surgicalperiodontaltherapypostpartum.
Int.J.Environ.Res.PublicHealth2019,16,3638 5of14
2.9. Outcomes
Primaryoutcomesofthepresentstudywerepretermbirthandlowbirthweight. Followingthe
WorldHealthOrganizationcriteria,pretermbirthwasdefinedasadeliveryat<37weeksofgestation
(gestationalagedeterminedbylastmenstrualperiodandultrasoundfetalmeasurement)andlowbirth
weightwasdefinedasanewbornweightof2500grorless. Secondaryoutcomeswerethoserelatedto
theefficacyofnon-surgicalperiodontaltherapyonclinical,biochemicalandmicrobiologicalvariables.
2.10. StatisticalAnalysis
Descriptive analysis was calculated for each variable (mean values, standard deviation).
Kolmogorov–Smirnovtestwasperformedtotestthenormalityofthevariables. Relationshipbetween
eachvariableandpretermbirth/lowbirthweightwereanalyzed. Allvariableswerealsocompared
between women with and without treatment. A t-student test was performed for continuous
variableswhilstAchi-squaretestwasusedtoanalyzecategoricalvariables. Non-normaldistribution
variableswereanalyzedbyaMann–WhitneyUtestforcontinuousvariablesandchi-squaretestfor
categoricalvariables. MultivariateanalysiswasperformedusingANCOVAtest,withpregnancyand
newbornweightasdependentvariableswithage,bodymassindexasacovariable,andtreatment
asanindependentvariable. Statisticalsignificancewasestablishedatthe95%confidenceleveland
p-values<0.05forallanalyseswereselectedtobestatisticallysignificant. SPSSforWindows(SPSSInc.
version20.0,Chicago,IL,USA)wasusedforallthestatisticalanalyses.
3. Results
Initially,66womenwereexaminedand50mettheinclusioncriteria. Eightrejectedtoparticipate
and two had a miscarriage. Finally, 40 women with periodontitis stage II grade B complied with
all the visits, 20 received non-surgical treatment (test group), and 20 received no treatment was
performed(controlgroup),asshowninFigure2. Noadverseeventsrelatedtoperiodontaltreatment
werereported.
DemographiccharacteristicsofthestudysampleareshowninTable1. Nostatisticallysignificant
differences were observed between groups. The study population was 32.00 ± 4.27 years old for
the test group and 32.25 ± 4.21 for control group; the majority lived in a rural residence, were
married,hadfinishedelementaryschool,andwereherfirstpregnancyandonlya5%hadaprevious
spontaneousabortion.
Int.J.Environ.Res.PublicHealth2019,16,3638 6of14
Figure2. Flowcharttoshowparticipantsprogressthroughthestudy.
Table1. Demographicdescriptionofthestudypopulation.
- TestGroup(n=20) ControlGroup(n=20)
Age(years,mean±SD) 32.14±4.27 32.25±4.21
BodyMassIndex(Kg/m2,mean±SD) 24.89±5.68 24.73±3.71
Educationlevel(n,%)
Primary 30% 35%
Secondary 40% 35%
University 30% 30%
Residence(n,%)
Rural 75% 90%
Urban 25% 10%
Maritalstatus(n,%)
Single 0% 5%
Common-lawpartner 40% 40%
Married 60% 55%
Previousspontaneousabortion(n,%)
Nospontaneousabortion 95% 95%
Onespontaneousabortion 5% 5%
Previouspregnancy(n,%)
Nopreviouspregnancy 80% 85%
Onepreviouspregnancy 20% 15%
Int.J.Environ.Res.PublicHealth2019,16,3638 7of14
Table 2 depicts the periodontal status of the study population. Selected pregnant women
presentedameannumberofteethinthetestgroupof26.95±1.21and26.32±2.77incontrolgroup,
with no significant differences between them. Bleeding on probing, probing pocket depth, and
clinical attachment level were statistically higher for the test group in the 1st trimester. However,
afternon-surgicalperiodontaltreatmenttheseparameterswerereversed,andasignificativereduction
wasverifiedinthe3rdtrimesterinthistestgroup.
Table2. Evolutionofclinicalparametersduringpregnancy.
ClinicalParameters 1stTrimester 2ndTrimester 3rdTrimester
Testgroup(n=20) 26.95±1.21 26.95±1.21 26.95±1.21
Numberofteeth
(mean±SD) Controlgroup(n=20) 26.32±2.77 26.32±2.77 26.32±2.77
p=0.32;CI p=0.32;CI p=0.32;CI
(−1.91–0.64) (−1.91–0.64) (−1.91–0.64)
Testgroup(n=20) 41.39±18.27 40.21±18.54 21.17±15.59
Plaqueindex
(mean±SD) Controlgroup(n=20) 32.96±20.08 34.36±18.68 35.68±17.64
p=0.54;CI p=0.32;CI p=0.01;CI
(−15.69–8.34) (−17.61–5.91) (3.99–25.01)
Bleedingon Testgroup(n=20) 48.30±14.80 54.57±18.61 27.88±15.29
probing
(mean±SD)
Controlgroup(n=20) 32.78±14.92 42.59±18.00 43.21±20.77
p=0.01;CI p=0.04;CI p=0.01;CI
(−23.81–−7.89) (−23.55–−0.40) (3.83–26.81)
Probingdepth Testgroup(n=20) 57.38±21.28 52.42±21.43 70.34±17.46
≤3mm
(%,mean±SD)
Controlgroup(n=20) 74.15±12.20 70.00±14.54 65.22±16.81
p=0.01;CI p=0.01;CI p=0.35;CI
(3.03–22.92) (5.95–29.21) (−15.95–5.72)
Probingdepth Testgroup(n=20) 35.64±17.34 39.88±19.12 24.39±12.30
4–5mm
(%,mean±SD)
Controlgroup(n=20) 24.69±10.36 26.11±10.67 29.87±12.96
p=0.09;CI p=0.01;CI p=0.17;CI
(−15.77–1.10) (−23.62–−3.92) (−2.50–13.46)
Probingdepth≥6 Testgroup(n=20) 6.90±9.59 7.69±10.55 5.31±8.87
(%,mean±SD)
Controlgroup(n=20) 3.68±1.17 4.27±6.95 4.77±6.08
p=0.01;CI p=0.23;CI p=0.82;CI
(−9.35–−1.72) (−9.10–2.25) (−5.37–4.29)
Clinicalattachment Testgroup(n=20) 0.74±0.38 0.77±0.46 0.69±0.57
loss≥3mm
(mm,mean±SD)
Controlgroup(n=20) 0.42±0.27 0.50±0.32 0.60±0.35
p=0.01;CI p=0.03;CI p=0.56;CI
(−0.46–−0.11) (−0.53–−0.18) (−0.39–0.21)
Student’st-testandUMann–Whitney.
Table3presentsthecytokinelevelsinperipheralbloodaccordingtoexperimentalgroupsand
experimentalperiods. Nosignificantdifferenceswereobservedforfibrinogen,IL-6,IL-8,andTNF-α
betweengroups.
Int.J.Environ.Res.PublicHealth2019,16,3638 8of14
Table3. Evolutionofbiochemicalparametersduringpregnancy.
BiochemicalParameters 1stTrimester 2ndTrimester 3rdTrimester
Testgroup(n=20) 365.06±55.12 387.06±49.25 447.65±52.27
Fibrinogen
(mg/dL,mean±SD) Con (ntro =l 2g 0r )oup 352.39±58.17 401.50±75.88 463.61±89.47
p=0.54;CI p=0.28;CI p=0.42;CI
(−42.28–22.47) (−18.43–61.76) (−29.59–68.79)
Testgroup(n=20) 7.80±3.87 7.17±3.20 6.97±2.65
TNF-α
(pg/mL,mean±SD) Con (ntro =l 2g 0r )oup 7.00±3.47 7.80±3.61 7.50±2.72
p=0.99;CI p=0.61;CI p=0.50;CI
(−2.07–2.06) (−1.52–2.55) (−1.08–2.15)
Testgroup(n=20) 3.04±2.56 2.54±1.33 2.84±1.42
Interleukin-6
(pg//mL,mean±SD) Con (ntro =l 2g 0r )oup 3.01±2.26 3.05±2.49 2.36±0.97
p=0.63;CI p=0.43;CI p=0.33;CI
(−1.55–0.95) (−0.70–1.61) (−1.06–0.37)
Testgroup(n=20) 14.94±19.09 10.24±6.27 11.41±10.26
Interleukin-8
(pg//mL,mean±SD) Con (ntro =l 2g 0r )oup 8.61±4.55 19.94±20.84 10.89±8.21
p=0.54;CI p=0.27;CI p=0.80;CI
(−9.55–5.13) (−4.64–16.25) (−6.15–4.76)
Student’st-testandUMann–Whitney.
Themicrobiologicalfindingsfrom40pregnantwomen,showedhighproportionsofdetectionof
Porphyromonasgingivalis,Fusobacteriumnucleatum,Prevotellaintermedia,andTannerellaforsythia. No
statisticallysignificantdifferenceswereobservedbetweenthecontrolandtestgroup. Table4shows
proportionsofdifferentbacterialspeciesintestgroupbefore(2ndtrimester)andaftertreatment(3rd
trimester),thisdifferencebeingstatisticallysignificantinsomebacteria.
Int.J.Environ.Res.PublicHealth2019,16,3638 9of14
Table4. Proportionsofdifferentbacterialspeciesintestandcontrolgroupsin2ndand3rdtrimester.
Microbiological
- 2ndTrimester 3rdTrimester p
Variables
Aggregatibacter Test(n=20) 0.98±3.00 0±0 (−20 .. 31 35 _; 0C .I
38)
actinomycetemcomitans
(%,mean±SD) Control(n=20) 0.30±2.83 0.28±3.12 (−20 .. 52 10 _; 0C .I
57)
Porphyromonasgingivalis
Test(n=20) 22.97±25.62 3.63±5.14 (−310 .. 10 71 –; −C 7I
.51)
(%,mean±SD)
Control(n=20) 23.38±18.23 24.59±19.22 (−20 0. .2 91 4; –C 5I
.01)
Prevotellaintermedia
Test(n=20) 2.60±1.20 0±0 (−3< .0 1. 40 –1 −; 2C .I
06)
(%,mean±SD)
Control(n=20) 2.79±1.42 2.54±1.55 (−20 .. 45 49 –; 1C .I
45)
Tannerellaforsythia
Test(n=20) 3.30±4.67 0±0 (−5< .0 4. 10 –1 −; 1C .I
19)
(%,mean±SD)
Control(n=20) 4.69±1.28 4.80±2.34 (−40 .. 56 64 –; 2C .I
89)
Parvimonamicra
Test(n=20) 0.73±1.65 0±0 (−10 .. 40 86 –; 0C .I
02)
(%,mean±SD)
Control(n=20) 1.68±3.72 1.86±3.02 (−10 .. 18 15 –; 1C .I
33)
Campylobacterrectus
Test(n=20) 1.72±7.33 0±0 (−50 .. 03 40 –; 1C .I
60)
(%,mean±SD)
Control(n=20) 1.32±3.72 1.33±3.83 (−50 .. 53 62 –; 1C .I
93)
Fusobacteriumnucleatum
Test(n=20) 1.96±2.68 0±0 (−3< .0 1. 70 –1 −; 0C .I
75)
(%,mean±SD)
Control(n=20) 2.18±1.82 2.20±2.30 (−40 .. 56 64 –; 2C .I
89)
Capnocytophaga
Test(n=20) 0.06±0.26 0±0 (−00 .. 13 82 –; 0C .I
06)
(%,mean±SD)
Control(n=20) 0.10±0.25 0.12±0.34 (−00 .. 11 69 –; 0C .I
03)
Eikenellacorrondens
Test(n=20) 0.40±1.13 0±0 (−00 .. 91 12 –; 0C .I
11)
(%,mean±SD)
Control(n=20) 1.31±1.91 1.22±1.23 (−10 .. 35 99 –; 2C .I
35)
Eubacteriumspp. Test(n=20) 0±0 0±0 -
(%,mean±SD) Control(n=20) 0±0 0±0 -
Student’st-testandUMann–Whitney.
Themeangestationaldurationwas38.25±2.88weeksforthecontrolgroupand37.72±6.04weeks
forthetestgroup. Meanweightatbirthwere3012.59±415.42gforthecontroland3249.48±473.54gfor
thetestgroup. Nostatisticallysignificantdifferenceswereobservedbetweengroupsforthesevariables.
Table5showsneonatalandobstetricoutcomes. Nosignificantdifferencesinpretermbirthrates
wereobservedbetweengroups(OR=0.28;CI=0.02–2.98). Similarly,theoccurrenceofnewbornswith
lowbirthweightwasnotsignificantlydifferentbetweengroups(OR=0.28;CI=0.02–2.98).
Int.J.Environ.Res.PublicHealth2019,16,3638 10of14
Table5. Primaryoutcomes.
TestGroup ControlGroup
PrimaryOutcomes Total
(n=20) (n=20)
No 19 17 36
†
PretermBirth
Yes 1 3 4
Total 20 20 40
No 19 17 36
‡
LowBirthWeight
Yes 1 3 4
Total 20 20 40
2×2Table(†,‡OR=0.28;CI=0.02–2.98).†PretermBirth;‡LowBirthWeight
Tables6and7describedpregnancytime(weeks)andnewbornweight(kg)asdependentvariables
andtherelationwithage,bodymassindex,andtreatment(independentvariables). Nosignificant
differenceswereobtained.
Table6.Dependentvariable:pregnancytime(weeks).ANCOVAanalysis.RSquared=0.019(Adjusted
RSquared=−0.065).
Variable TypeIIISumofSquares p
Age 0.206 NS
BodyMassIndex 0.181 NS
Treatment 1.194 NS
NS:notsignificant.
Table7. Dependentvariable: newbornweight(kg). ANCOVAanalysis. RSquared=0.116(AdjustedR
Squared=−0.040).
Variable TypeIIISumofSquares p
Age 91,359.53 NS
BodyMassIndex 1555.01 NS
Treatment 685,694.99 NS
NS:notsignificant.
4. Discussion
Themainobjectiveofthisstudywastoevaluatetheeffectsofnon-surgicalperiodontaltreatment
inpregnantwomen,carriedoutduringthesecondtrimesterofpregnancy,ontheratesofpretermbirth
andlowbirthweight,andtoassesstheclinical,biochemical,andmicrobiologicalchanges. Theeffectof
periodontalinterventiononpregnancyoutcomesdidnotshowareductionintheriskofpretermbirth
andlowbirthweightinthetestgroupcomparedtothecontrolgroup. However,wecanassumeas
clinicallyrelevanttheprotectorroleofperiodontitistreatmentduringpregnancy(ANCOVAanalysis),
duetothesignificantperiodontalhealthimprovementinthetestgroup. Pregnancyisashortperiod
oftimeinordertoevaluatethesystemicimpactofalongtermperiodontalmicrobialinfectionand
relatedinflammatoryresponses.
ThisfindingissupportedbypreviousstudiessuchasOliveiraetal.[31],Offenbacheretal.[30],
andMichalowiczetal.[38];theseauthorsdemonstratedthatthetreatmentofperiodontitisinpregnant
womenwassafeandeffectiveforperiodontaldisease,butdidnotreducetheincidenceofpremature
delivery and low birth weight. The meta-analysis conducted by Baccaglini in 2011 [39] including
elevenhighqualityrandomizedcontrolledtrialsperformedon6558pregnantwomen,alsoshowedno
evidencetosupportthatnon-surgicalperiodontaltreatmentduringpregnancypreventspremature
birthorotheradversepregnancyoutcomes.
Int.J.Environ.Res.PublicHealth2019,16,3638 11of14
Conversely,somepapershavesuggestedapositiveeffectofnon-surgicalperiodontaltreatment
both in the periodontal condition of the patient and in the adverse results of pregnancy.
Offenbacheretal.[24] showed that periodontal treatment reduced 3.8 times the rate of premature
births;thismaybeduetothefactthatmanyoftheincludedpatientshadadisadvantagedeconomic
statusandhadpreviouslyhadpretermbirths(>12weeks),therefore,thisstudypopulationrepresented
ahigh-riskgroup. Jeffcoatetal.[23]showedthatsuccessfulperiodontaltherapyreducedtheriskof
prematuredeliveryinagroupofAfrican-Americanwomenwhohadnevervisitedadentist,buttheir
resultscannotbeextrapolatedtootherpopulationswithdifferentcharacteristics. Radnaietal.[25]
also showed that periodontal treatment had a positive pregnancy outcome in a demographically
homogenous Caucasian European population, but these women had an initial localized chronic
periodontitis. Tarannumetal.[26]providedevidencethatnon-surgicalperiodontaltherapycanreduce
the risk of preterm birth/low birth weight, but the study population was Indian, belonged to low
socio-economicstrata(basedonoccupation),hadloweducationlevels,andpatientswithahistory
ofalcohol/tobaccoconsumptionwerenotexcluded. Finally,Lópezetal.[8]alsodemonstratedthe
positiveeffectofperiodontaltreatmentinadversepregnancyoutcomesinpatientsdiagnosedwith
gingivitis and periodontitis, but the periodontal treatment included a daily chlorhexidine rinse at
0.12%andwomenwithurinarytractinfectionsweretreatedwithantibiotics(anexclusioncriteriain
moststudies).
Whentheclinicalvariableswereanalyzed,wehavetoconsiderthatbleedingonprobing,probing
pocketdepth,andclinicalattachmentlevelwerestatisticallyhigherforthetestthanforthecontrol
groupinthe1sttrimester,howeverbothgroupswerediagnosedwithperiodontitisstageII,grade
B[34]. Theseclinicalparametersremainedstablethroughoutthegestationalperiodinthecontrolgroup
andaftertreatmentinthetestgroup,therewasasignificativedecreaseinthepercentageofbleeding
onprobing,plaqueindex,averageprobingpocketdepth,andclinicalattachmentloss. Thesefindings
forthecontrolgroupseemstohavenocorrelationwithplaqueaccumulationsinceithasbeenshown
thatthehormonalchangesthatoccurduringpregnancyareamodifyingfactorofbacterialplaque[40].
SantaCruzetal.[9]showedthatperiodontalclinicalstatuswasnotassociatedwithadversepregnancy
outcomesinaCaucasianSpanishpopulationwithamedium–higheducationallevel.
Biochemicalmarkersincreasedinthethirdtrimesterfollowingthebasicperiodontaltreatment,
exceptTNF-α,whichdecreasedafterperformingthetreatment. Thedifferencesbetweenthetreatment
group and the control group were not significant for any of the three visits. Most authors agree
that treatment of chronic periodontitis does not significantly change levels of serum markers of
acute-phase inflammatory and vascular response [41]. It has been suggested that non-surgical
mechanicalperiodontaltreatmentduringpregnancysuccessfullyreducesperiodontalinflammation
andgingivalcrevicularfluidcytokinelevels,butithasnosignificantimpactonserumbiomarkers[38,42].
Thecompleximmunologicaleventsthatoccurduringpregnancymaylimittheabilitytoevaluatethe
systemiceffectofperiodontaltherapy,becausestudieshaveshownthatpregnantwomenhaveahigher
productionofcytokinesdependingonthegestationalperiodandtheoutcomeofpregnancy[42].
Regardingthepresenceofperiodontopathogens,thenon-surgicalperiodontaltreatmentperformed
inthesecondtrimesterreducedthenumberofallthesubgingivalperiodontalpathogensanalyzed
andthetotalbacterialload. Thesefindingsindicatethattheperiodontaltherapyofpregnantwomen
withperiodontitisproducesquantitativeandqualitativechangesinthemicrobiotasimilartothose
observedinnon-pregnantwomen[43]. Pregnantwomenwithperiodontitisharboraverycomplex
and pathogenic subgingival microbiota, including a high prevalence of Fusobacterium nucleatum,
Prevotellaintermedia,Porphyromonasgingivalis,andParvimonamicra[9]. Martínez-Martínezetal.[44]
did not find association between periodontal bacteria and premature birth. In opposition to this,
SantaCruzetal.[9]foundasignificantassociationbetweenthepresenceofEikenellacorrodenswith
pretermbirthandthepresenceofCapnocytophagaspp. withlowbirthweight. Novaketal.[43]showed
that basic periodontal therapy significantly reduced the levels of periodontal pathogens but basal
levelsofthesewerenotassociatedwithprematurebirth.
Int.J.Environ.Res.PublicHealth2019,16,3638 12of14
Thepresentstudyisnotexemptfromanumberofmethodologicallimitationsthatshouldbe
consideredwhenextrapolatingourresults. Uptodate,availableevidencedoesnotprovideclinical,
microbiological,orimmunologicalparametersthatdefinepatientswhosepregnancyoutcomeswould
be improved with periodontal treatment [10]. The selected study group of our study consisted of
Caucasian women between 18 and 40 years old and according to the literature the most affected
populationbyperiodontitisistheAfrican-Americanpopulation. Theperiodontitisdefinitionthatwe
haveappliedincontrasttopreviouspapersistheonerecentlypublishedbytheEFP-AAPConsensus
Meeting[34]. Basedonepidemiologicalandplausibilitystudies,varioustreatmentstrategiescouldbe
evaluatedthatconsiderspecifictargetpopulations,aswellastimingandintensityoftreatment[10].
5. Conclusions
Wecanconcludethatnon-surgicalperiodontaltreatmentinCaucasianpatientswithperiodontitis
stageIIgradeBdidnotsignificantlyreducetheriskofadversepregnancyoutcomes.
AuthorContributions: Conceptualization,J.L.-C.andJ.B.-C.;Datacuration,L.C.-Q.andP.M.-L.;Formalanalysis,
P.M.-L.;Fundingacquisition,J.B.-C.;Investigation,L.C.-Q.;Methodology,J.L.-C.andJ.B.-C.;Projectadministration,
J.B.-C.;Resources,J.L.-C.;Supervision,J.L.-P.;Visualization,P.D.-D.;Writing—originaldraft,L.C.-Q.andP.D.-D.;
Writing—review&editing,J.L.-C.andJ.L.-P.
Funding: Thisresearchreceivednoexternalfunding.
ConflictsofInterest: Theauthorsdeclarenoconflictofinterest.
References
1. Mathews, T.J.; Menacker, F.; MacDorman, M.F. Infant mortality statistics from the 2001 period linked
birth/infantdeathdataset. Natl. VitalStat. Rep. 2003,52,1–28. [PubMed]
2. Chang,H.H.;Larson,J.;Blencowe,H.;Spong,C.Y.;Howson,C.P.;Cairns-Smith,S.;Lackritz,E.M.;Lee,S.K.;
Mason,E.; Serazin,A.C.; etal. Preventingpretermbirths: Analysisoftrendsandpotentialreductions
withinterventionsin39countrieswithveryhighhumandevelopmentindex. Lancet2013,381,223–234.
[CrossRef]
3. Blencowe,H.;Cousens,S.;Jassir,F.B.;Say,L.;Chou,D.;Mathers,C.;Hogan,D.;Shiekh,S.;Qureshi,Z.U.;
You,D.;etal. National,regional,andworldwideestimatesofstillbirthratesin2015,withtrendsfrom2000:
Asystematicanalysis. LancetGlob. Health2016,4,e98–e108. [CrossRef]
4. Purisch,S.E.;Gyamfi-Bannerman,C.Epidemiologyofpretermbirth. Semin. Perinatol. 2017,41,387–391.
[CrossRef][PubMed]
5. Vogel, J.P.; Chawanpaiboon, S.; Moller, A.-B.; Watananirun, K.; Bonet, M.; Lumbiganon, P. The global
epidemiologyofpretermbirth. BestPract. Res. Clin. Obstet. Gynaecol. 2018,52,3–12. [CrossRef][PubMed]
6. Kornman, K.S.; Page, R.C.; Tonetti, M.S. The host response to the microbial challenge in periodontitis:
Assemblingtheplayers. Periodontology2000,14,33–53. [CrossRef]
7. Carta,G.;Persia,G.;Falciglia,K.;Iovenitti,P.Periodontaldiseaseandpoorobstetricaloutcome. Clin. Exp.
Obstet. Gynecol. 2004,31,47–49.
8. Lopez,N.J.;DaSilva,I.;Ipinza,J.;Gutiérrez,J.PeriodontalTherapyReducestheRateofPretermLowBirth
WeightinWomenwithPregnancy-AssociatedGingivitis. J.Periodontol. 2005,76,2144–2153. [CrossRef]
9. SantaCruz,I.;Herrera,D.;Martin,C.;Herrero,A.;Sanz,M.Associationbetweenperiodontalstatusand
pre-termand/orlow-birthweightinSpain: Clinicalandmicrobiologicalparameters. J.PeriodontalRes. 2013,
48,443–451. [CrossRef]
10. Sanz,M.;Kornman,K.Workinggroup3ofjointEFP/AAPworkshop. Periodontitisandadversepregnancy
outcomes: ConsensusreportoftheJointEFP/AAPWorkshoponPeriodontitisandSystemicDiseases. J.Clin.
Periodontol. 2013,84,S164–S169. [CrossRef]
11. Gürsoy,M.;Könönen,E.;Gursoy,U.K.;Tervahartiala,T.;Pajukanta,R.;Sorsa,T.PeriodontalStatusand
NeutrophilicEnzymeLevelsinGingivalCrevicularFluidduringPregnancyandPostpartum. J.Periodontol.
2010,81,1790–1796. [CrossRef][PubMed]
12. Madianos,P.N.;Bobetsis,Y.A.;Offenbacher,S.Adversepregnancyoutcomes(APOs)andperiodontaldisease:
Pathogenicmechanisms. J.Clin. Periodontol. 2013,40,170–180. [CrossRef][PubMed]
Int.J.Environ.Res.PublicHealth2019,16,3638 13of14
13. Minckwitz,G.;Grischke,E.-M.;Schwab,S.;Hettinger,S.;Loibl,S.;Aulmann,M.;Kaufmann,M.Predictive
valueofseruminterleukin-6and-8levelsinpretermlabororruptureofthemembranes. ActaObstet. Gynecol.
Scand. 2000,79,667–672.
14. Gücer,F.;Balkanli-Kaplan,P.;Yüksel,M.;AYüce,M.;Türe,M.;Yardim,T.Maternalserumtumornecrosis
factor-alphainpatientswithpretermlabor. J.Reprod. Med. 2001,46,232–236. [PubMed]
15. Pitiphat,W.; Gillman,M.W.; Joshipura,K.J.; Williams,P.L.; Douglass,C.W.; Rich-Edwards,J.W.Plasma
C-reactiveproteininearlypregnancyandpretermdelivery.Am.J.Epidemiol.2005,162,1108–1113.[CrossRef]
[PubMed]
16. Agueda,A.;Ramón,J.;Manau,C.;Guerrero,A.;Echeverria,J.Periodontaldiseaseasariskfactorforadverse
pregnancyoutcomes: Aprospectivecohortstudy. J.Clin. Periodontol. 2008,35,16–22. [CrossRef]
17. Offenbacher,S.;Boggess,K.A.;Murtha,A.P.;Jared,H.L.;Lieff,S.;McKaig,R.G.;Mauriello,S.M.;Moss,K.L.;
Beck,J.D.ProgressivePeriodontalDiseaseandRiskofVeryPretermDelivery. Obstet. Gynecol. 2006,107,
29–36. [CrossRef]
18. Rakoto-Alson,S.; Tenenbaum,H.; Davideau,J.-L.PeriodontalDiseases, PretermBirths, andLowBirth
Weight: FindingsfromaHomogeneousCohortofWomeninMadagascar. J.Periodontol. 2010,81,205–213.
[CrossRef]
19. Matevosyan,N.R.Periodontaldiseaseandperinataloutcomes. Arch. Gynecol. Obstet. 2011,283,675–686.
[CrossRef]
20. Vergnes,J.N.;Sixou,M.Pretermlowbirthweightandmaternalperiodontalstatus: Ameta-analysis. Am. J.
Obstet. Gynecol. 2007,196,135.e1–135.e7. [CrossRef]
21. Puertas,A.;Magan-Fernandez,A.;Blanc,V.;Revelles,L.;O´Valle,F.;Pozo,E.;León,R.;Mesa,F.Association
ofperiodontitiswithpretermbirthandlowbirthweight: Acomprehensivereview. J.Materm. FetalNeonatal
Med. 2018,31,597–602. [CrossRef][PubMed]
22. Teshome,A.;Yitayeh,A.Relationshipbetweenperiodontaldiseaseandpretermlowbirthweight:Systematic
review. PanAfr. Med. J.2016,24,215. [CrossRef][PubMed]
23. Jeffcoat,M.;Parry,S.;Sammel,M.;Clothier,B.;Catlin,A.;Macones,G.Periodontalinfectionandpreterm
birth: Successfulperiodontaltherapyreducestheriskofpretermbirth. BJOGInt. J.Obstet. Gynaecol. 2011,
118,635–636. [CrossRef]
24. Offenbacher,S.;Lin,D.;Strauss,R.;McKaig,R.;Irving,J.;Barros,S.P.;Moss,K.;Barrow,D.A.;Hefti,A.;
Beck,J.D.EffectsofPeriodontalTherapyDuringPregnancyonPeriodontalStatus,BiologicParameters,and
PregnancyOutcomes: APilotStudy. J.Periodontol. 2006,77,2011–2024. [CrossRef][PubMed]
25. Radnai,M.;Pal,A.;Novák,T.;Urban,E.;Eller,J.;Gorzo,I.BenefitsofPeriodontalTherapyWhenPreterm
BirthThreatens. J.Dent. Res. 2009,88,280–284. [CrossRef][PubMed]
26. Tarannum,F.;Faizuddin,M.EffectofPeriodontalTherapyonPregnancyOutcomeinWomenAffectedby
Periodontitis. J.Periodontol. 2007,78,2095–2103. [CrossRef][PubMed]
27. Macones,G.A.;Parry,S.;Nelson,D.B.;Strauss,J.F.;Ludmir,J.;Cohen,A.W.;Stamilio,D.M.;Appleby,D.;
Clothier,B.;Sammel,M.D.;etal. Treatmentoflocalizedperiodontaldiseaseinpregnancydoesnotreduce
theoccurrenceofpretermbirth: ResultsfromthePeriodontalInfectionsandPrematurityStudy(PIPS).Am.
J.Obstet. Gynecol. 2010,202,147.e1–147.e8. [CrossRef]
28. Michalowicz,B.S.; Hodges,J.S.; DiAngelis,A.J.; Lupo,V.R.; Novak,M.J.; Ferguson,J.E.; Buchanan,W.;
Bofill,J.;Papapanou,P.N.;Mitchell,D.A.;etal. TreatmentofPeriodontalDiseaseandtheRiskofPreterm
Birth. N.Engl. J.Med. 2006,355,1885–1894. [CrossRef]
29. Merchant,A.T.;Sutherland,M.W.;Liu,J.;Pitiphat,W.;Dasanayake,A.Periodontaltreatmentamongmothers
withmildtomoderateperiodontaldiseaseandpretermbirth: ReanalysisofOPTtrialdataaccountingfor
selectivesurvival. Int. J.Epidemiol. 2018,47,1670–1678. [CrossRef]
30. Offenbacher, S.; Beck, J.D.; Jared, H.L.; Mauriello, S.M.; Mendoza, L.C.; Couper, D.J.; Stewart, D.D.;
Murtha,A.P.;Cochran,D.L.;Dudley,D.J.;etal. Effectsofperiodontaltherapyonrateofpretermdelivery: A
randomizedcontrolledtrial. Obstet. Gynecol. 2009,114,551–559. [CrossRef]
31. Oliveira,A.M.;deOliveira,P.A.;Cota,L.O.;Magalhaes,C.S.;Moreira,A.N.;Costa,F.O.Periodontaltherapy
andriskforadversepregnancyoutcomes. Clin. Oral. Investig. 2011,15,609–615. [CrossRef][PubMed]
32. Kinane,D.;Bouchard,P.OnbehalfofgroupEoftheEuropeanWorkshoponPeriodontologyPeriodontal
diseases and health: Consensus Report of the Sixth European Workshop on Periodontology. J. Clin.
Periodontol. 2008,35,333–337. [CrossRef][PubMed]
Int.J.Environ.Res.PublicHealth2019,16,3638 14of14
33. Chambrone,L.;Pannuti,C.M.;Guglielmetti,M.R.;Chambrone,L.A.Evidencegradeassociatingperiodontitis
withpretermbirthand/orlowbirthweight: II.Asystematicreviewofrandomizedtrialsevaluatingthe
effectsofperiodontaltreatment. J.Clin. Periodontol. 2011,38,902–914. [CrossRef][PubMed]
34. Papapanou, P.N.; Sanz, M.; Buduneli, N.; Dietrich, T.; Feres, M.; Fine, D.H.; Flemmig, T.F.; Garcia, R.;
Giannobile,W.V.;Graziani,F.;etal. Periodontitis: Consensusreportofworkgroup2ofthe2017World
WorkshopontheClassificationofPeriodontalandPeri-ImplantDiseasesandConditions. J.Clin. Periodontol.
2018,45,S162–S170. [CrossRef][PubMed]
35. Ainamo,J.;Bay,I.Problemsandproposalsforrecordinggingivitisandplaque. Int. Dent. J.1975,25,229–235.
[PubMed]
36. Syed,S.A.;Loesche,W.J.SurvivalofHumanDentalPlaqueFlorainVariousTransportMedia. Appl. Microbiol.
1972,24,638–644. [PubMed]
37. Alsina, M.; Olle, E.; Frías, J. Improved, Low-Cost Selective Culture Medium for Actinobacillus
actinomycetemcomitans. J.Clin. Microbiol. 2001,39,509–513. [CrossRef]
38. Michalowicz,B.S.;Novak,M.J.;Hodges,J.S.;DiAngelis,A.;Buchanan,W.;Papapanou,P.N.;Mitchell,D.A.;
Ferguson, J.E.; Lupo, V.; Bofill, J.; et al. Serum inflammatory mediators in pregnancy: Changes after
periodontal treatment and association with pregnancy outcomes. J. Periodontol. 2009, 80, 1731–1741.
[CrossRef]
39. Baccaglini,L.Ameta-analysisofrandomizedcontrolledtrialsshowsnoevidencethatperiodontaltreatment
during pregnancy prevents adverse pregnancy outcomes. J. Am. Dent. Assoc. 2011, 142, 1192–1193.
[CrossRef]
40. Kaur,M.;Geisinger,M.L.;Geurs,N.C.;Griffin,R.;Vassilopoulos,P.J.;Vermeulen,L.;Haigh,S.;Reddy,M.S.
Effect of intensive oral hygiene regimen during pregnancy on periodontal health, cytokine levels, and
pregnancyoutcomes: Apilotstudy. J.Periodontol. 2014,85,1684–1692. [CrossRef]
41. Ide,M.;McPartlin,D.;Coward,P.;Crook,M.;Lumb,P.;Wilson,R.Effectoftreatmentofchronicperiodontitis
onlevelsofserummarkersofacute-phaseinflammatoryandvascularresponses. J.Clin. Periodontol. 2003,
30,334–340. [CrossRef][PubMed]
42. Fiorini,T.;Susin,C.;daRocha,J.M.;Weidlich,P.;Vianna,P.;Moreira,C.H.;BogoChies,J.A.;Rösing,C.K.;
Oppermann,R.V.Effectofnonsurgicalperiodontaltherapyonserumandgingivalcrevicularfluidcytokine
levelsduringpregnancyandpostpartum. J.PeriodontalRes. 2013,48,126–133. [CrossRef][PubMed]
43. Novak,M.J.; Novak,K.F.; Hodges,J.S.; Kirakodu,S.; Govindaswami,M.; DiAngelis,A.; Buchanan,W.;
Papapanou,P.N.;Michalowicz,B.S.PeriodontalBacterialProfilesinPregnantWomen:ResponsetoTreatment
andAssociationswithBirthOutcomesintheObstetricsandPeriodontalTherapy(OPT)Study. J.Periodontol.
2008,79,1870–1879. [CrossRef][PubMed]
44. Martínez-Martínez, R.E.; Moreno-Castillo, D.F.; Loyola-Rodríguez, J.P.; Sánchez-Medrano, A.G.;
Miguel-Hernández,J.H.;Olvera-Delgado,J.H.;Domínguez-Pérez,R.A.Associationbetweenperiodontitis,
periodontopathogensandpretermbirth: Isitreal? Arch. Gynecol. Obstet. 2016,294,47–54. [CrossRef]
©2019bytheauthors. LicenseeMDPI,Basel,Switzerland. Thisarticleisanopenaccess
articledistributedunderthetermsandconditionsoftheCreativeCommonsAttribution
(CCBY)license(http://creativecommons.org/licenses/by/4.0/).
